AU2002224845A1 - Viral expression system - Google Patents

Viral expression system

Info

Publication number
AU2002224845A1
AU2002224845A1 AU2002224845A AU2484502A AU2002224845A1 AU 2002224845 A1 AU2002224845 A1 AU 2002224845A1 AU 2002224845 A AU2002224845 A AU 2002224845A AU 2484502 A AU2484502 A AU 2484502A AU 2002224845 A1 AU2002224845 A1 AU 2002224845A1
Authority
AU
Australia
Prior art keywords
expression system
viral expression
viral
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224845A
Inventor
Klaus Hellmuth
Georg Orberger
Christian Wagener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARIMEDES BIOTECHNOLOGY GmbH
Original Assignee
ARIMEDES BIOTECHNOLOGY GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARIMEDES BIOTECHNOLOGY GmbH filed Critical ARIMEDES BIOTECHNOLOGY GmbH
Publication of AU2002224845A1 publication Critical patent/AU2002224845A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002224845A 2000-11-13 2001-11-13 Viral expression system Abandoned AU2002224845A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10056210.8 2000-11-13
DE2000156210 DE10056210A1 (en) 2000-11-13 2000-11-13 Viral expression system
PCT/EP2001/013125 WO2002038782A2 (en) 2000-11-13 2001-11-13 Viral expression system

Publications (1)

Publication Number Publication Date
AU2002224845A1 true AU2002224845A1 (en) 2002-05-21

Family

ID=7663136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224845A Abandoned AU2002224845A1 (en) 2000-11-13 2001-11-13 Viral expression system

Country Status (3)

Country Link
AU (1) AU2002224845A1 (en)
DE (1) DE10056210A1 (en)
WO (1) WO2002038782A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2292271B1 (en) * 2004-05-20 2009-02-16 Proyecto De Biomedicina Cima, S.L. AN ADENOVIRUS-ALFAVIRUS HYBRID VECTOR FOR THE EFFECTIVE ADMINISTRATION AND EXPRESSION OF THERAPEUTIC GENES IN TUMOR CELLS.
ES2982489T3 (en) 2016-08-19 2024-10-16 Univ Florida Compositions for the treatment of conditions using self-complementary recombinant adeno-associated viruses
JP7282378B2 (en) 2016-12-07 2023-05-29 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド IL-1Ra cDNA
TW202039856A (en) * 2019-03-28 2020-11-01 西班牙商艾斯提夫製藥股份有限公司 Methods for the manufacture of recombinant viral vectors
US20230159950A1 (en) * 2020-03-17 2023-05-25 Biogen Ma Inc. Methods and compositions for production of recombinant adeno-associated viruses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11514853A (en) * 1995-09-08 1999-12-21 ジエンザイム コーポレイション Improved AAV vector for gene therapy
US6004797A (en) * 1995-11-09 1999-12-21 Avigen, Inc. Adenovirus helper-free recombinant AAV Virion production
WO1998010087A1 (en) * 1996-09-06 1998-03-12 Trustees Of The University Of Pennsylvania Chimpanzee adenovirus vectors
AU3097399A (en) * 1998-03-20 1999-10-11 Trustees Of The University Of Pennsylvania, The Compositions and methods for helper-free production of recombinant adeno-associated viruses
GB9811171D0 (en) * 1998-05-22 1998-07-22 Royal Free Hosp School Med Viral vector
US6258595B1 (en) * 1999-03-18 2001-07-10 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
AU3274401A (en) * 2000-01-05 2001-07-16 Fred Hutchinson Cancer Research Center Compositions and methods for efficient aav vector production

Also Published As

Publication number Publication date
WO2002038782A2 (en) 2002-05-16
DE10056210A1 (en) 2002-05-29
WO2002038782A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
AU2001239746A1 (en) Group-browsing system
AU2001266971A1 (en) Secure forwarding system
AU2001284246A1 (en) Electrosurgery system
AU2001284681A1 (en) Fluidics system
AUPQ802400A0 (en) Propulsion system
AU2001236285A1 (en) Self-configurable distributed system
AU2001259186A1 (en) Ticketless admission system
AUPP967999A0 (en) Viral variants
AU2002212516A1 (en) Suspension system
AU2001263157A1 (en) Tine system
AU2001288668A1 (en) Micro-fluidic system
AU2001284775A1 (en) Anti-balling system
AU2002243257A1 (en) Oncolytic virus
AU2001260461A1 (en) Location system
AU2002224845A1 (en) Viral expression system
AU2002213484A1 (en) Multi-dose container system
AU2001289885A1 (en) Air-preparation system
AU2001223394A1 (en) Framework system
AU7567101A (en) Gene expression system
AU6001200A (en) Expression system
AU2001289075A1 (en) Enhanced transfection system
AU4082101A (en) Scaffolding system
AU2001258116A1 (en) Distributed discovery system
AU2001293667A1 (en) Buckle-fastener system
AU2001278704A1 (en) Receiving system